Page 10 - Orthofeed_Issue4_Feb2022

Bibliometric Analysis of Thromboprophylaxis in Orthopaedic Surgery 09

absolute risk of the composite of deep-vein Thrombosis and Haemostasis; JBJS, The orthopedic, and urologic surgery. N Engl J Med. 1988;
318(18):1162-1173.
thrombosis, non-fatal pulmonary embolism, and Journal of Bone and Joint Surgery; Arch Int
death from any cause by 9.2%. In this Med, The Archives of Internal Medicine) 7) Eriksson BI, Borris LC, Friedman RJ, Haas S, Huisman
7
MV, Kakkar AK, Bandel TJ, Beckmann H, Muehlhofer E,
randomized controlled trial involving 2459 Misselwitz F, Geerts W; RECORD1 Study Group.
Rivaroxaban versus enoxaparin for thromboprophylaxis
patients undergoing hip arthroplasty, Conclusion after hip arthroplasty. N Engl J Med. 2008

rivaroxaban showed a decrease in risk of major Thromboprophylaxis is one of the most crucial 6;358(26):2765-2775.
venous thromboembolism by 1.6% than aspect of orthopaedic surgery and remains at 8) Turpie AG, Haas S, Kreutz R, Mantovani LG, Pattanayak
CW, Holberg G, Jamal W, Schmidt A, van Eickels M,
enoxaparin. More recent studies have replicated the forefront of research and surgery Lassen MR. A non-interventional comparison of
7
similar findings. Thus, factor Xa inhibitors are considerations. The present report presented a rivaroxaban with standard of care for thromboprophylaxis
8
after major orthopaedic surgery in 17,701 patients with
considered a viable alternative to low molecular favourable trend towards high impact research propensity score adjustment. Thromb Haemost. 2014;
111(1):94-102.
weight heparins (LMWHs) in both ACCP and within orthopedic thromboprophylaxis. Studies
4
American Academy of Orthopaedic Surgeons included in analysis were highly cited for a 9) Johanson NA, Lachiewicz PF, Lieberman JR, Lotke PA,
Parvizi J, Pellegrini V, Stringer TA, Tornetta P 3rd, Haralson
(AAOs) guidelines. 9, 10 multitude of factors like clinical significance, RH 3rd, Watters WC 3rd. American academy of
orthopaedic surgeons clinical practice guideline on.
study quality, and importance in orthopaedics Prevention of symptomatic pulmonary embolism in
4
Top Journals publishing on DVT prophylaxis in research. Such studies improve our patients undergoing total hip or knee arthroplasty. J Bone
Joint Surg Am. 2009; 91(7):1756-1757.
orthopedic surgery: understanding about the ever-changing 10) Falck-Ytter Y, Francis CW, Johanson NA, Curley C,

The top three journals with the greatest number landscape of anticoagulation regimens as well Dahl OE, Schulman S, Ortel TL, Pauker SG, Colwell CW Jr.
of publications in the list of 100 (Figure 2) were: as DVT prophylaxis in orthopaedic surgery. 4 Prevention of VTE in orthopedic surgery patients:
Antithrombotic Therapy and Prevention of Thrombosis,
1) The Journal of Thrombosis and 9th ed: American College of Chest Physicians
Evidence-Based Clinical Practice Guidelines. Chest. 2012;
Haemostasis (impact factor: 4.662) References 141(2 Suppl):e278S-e325S.

2) The Journal of Bone and Joint Surgery 1) Warren JA, Sundaram K, Anis HK, Kamath AF, Higuera
(impact factor: 4.31) CA, Piuzzi NS. Have Venous Thromboembolism Rates
a) The highest cited article: general, orthopaedic, and urologic surgery 3) The Archives of Internal Medicine (JAMA) Decreased in Total Hip and Knee Arthroplasty? J
Arthroplasty. 2020; 35(1):259-264.
The 8th edition of American College of Chest (1988) captured some of the earliest high quality (impact factor: 20.77). 2) Flevas DA, Megaloikonomos PD, Dimopoulos L,

Physician (ACCP) Guidelines- Prevention of findings in orthopaedic thromboprophylaxis. 6 Mitsiokapa E, Koulouvaris P, Mavrogenis AF.
Thromboembolism prophylaxis in orthopaedics: an
venous thromboembolism published in Chest in update. EFORT Open Rev. 2018; 3(4):136-148.

2008 had a calculated citation density of 215.54 c) The third highest cited article:
25 3) Thompson DF, Walker CK. A descriptive and historical
of citations/year since publication. The most Rivaroxaban versus enoxaparin for review of bibliometrics with applications to medical
5
probable explanation for the high number of thromboprophylaxis after hip arthroplasty (2008) 20 sciences. Pharmacotherapy. 2015; 35(6):551-559
citations of the ACCP guidelines is the broad, highlighted both the role of novel factor Xa 15 4) Sedani A, Yakkanti R, Allegra P, Mattingly L, Aiyer A.
Thromboprophylaxis across orthopaedic surgery:
multidisciplinary recommendations put forward inhibitors and the driving force of arthroplasty in Percentage of publications 10 Bibliometric analysis of the most cited articles. J Clin
by the experts. 4 DVT literature. 7 5 Orthop Trauma. 2021; 23;16:157-167.
5) Geerts WH, Bergqvist D, Pineo GF, Heit JA, Samama
CM, Lassen MR, Colwell CW. Prevention of venous
b) The second highest cited article: Rivaroxaban in thromboprophylaxis: 0 thromboembolism: American College of Chest Physicians
JTH JBJS Arch Evidence-Based Clinical Practice Guidelines (8th Edition).
Reduction in fatal pulmonary embolism and The literature analysis demonstrated that Int Med Chest. 2008; 133(6 Suppl):381S-453S.
(JAMA)
venous thrombosis by perioperative investigators have actively studied the efficacy
6) Collins R, Scrimgeour A, Yusuf S, Peto R. Reduction in
administration of subcutaneous heparin - of rivaroxaban in orthopaedic surgery. Figure 2: Top three journals with highest fatal pulmonary embolism and venous thrombosis by
3
overview of results of randomized trials in Rivaroxaban has been found to reduce the percentage of articles (JTH, Journal of perioperative administration of subcutaneous heparin.
Overview of results of randomized trials in general,